Arlington Heights, IL Macular Degeneration Treatment

Age-related macular degeneration (AMD) is an eye disease that affects the macula, the central part of the retina responsible for sharp, detailed vision. As AMD progresses, it can make activities such as reading, driving, recognizing faces, and seeing fine details more difficult.

Common symptoms of macular degeneration include:

• Blurred central vision
• Straight lines appearing wavy or distorted
• Difficulty reading
• Trouble recognizing faces
• Dark or blank spots in central vision
• Reduced color perception

Symptoms often develop gradually with dry AMD but may appear suddenly with wet AMD.

Dry macular degeneration is the most common form and typically progresses slowly as the macula becomes thinner over time. Wet macular degeneration occurs when abnormal blood vessels grow beneath the retina and leak fluid or blood, causing rapid vision changes that require prompt treatment.

Several factors increase your risk, including:

• Being over age 50
• Family history of AMD
• Smoking
• High blood pressure
• Obesity
• Cardiovascular disease
• Prolonged UV exposure

Routine comprehensive eye exams become increasingly important as you age.

There is currently no cure for age-related macular degeneration. However, early diagnosis and treatment can slow disease progression, preserve vision, and help patients maintain their quality of life.

Your ophthalmologist may use several tests to diagnose AMD, including:

• Comprehensive dilated eye examination
• Optical Coherence Tomography (OCT)
• Retinal imaging
• Amsler grid testing
• Fluorescein angiography when indicated

These tests help determine the type and severity of macular degeneration.

Wet AMD is commonly treated with anti-VEGF medications that are injected into the eye to reduce abnormal blood vessel growth and leakage. In some cases, laser treatments or other retinal therapies may also be appropriate.

Although there is no cure for dry AMD, treatment focuses on slowing progression through regular monitoring, lifestyle modifications, nutritional supplements for appropriate patients, and management of risk factors. Your ophthalmologist will determine whether you may benefit from AREDS2 nutritional supplements.

Anti-VEGF medications are injected into the eye to block the growth of abnormal blood vessels responsible for wet macular degeneration. These treatments help reduce retinal swelling, slow disease progression, and preserve vision in many patients.

Most patients experience very little discomfort. Before treatment, numbing eye drops and antiseptic preparations are used to keep the procedure as comfortable as possible. The injection itself typically takes only a few seconds.

Treatment schedules vary depending on the medication used and your response. Some patients require monthly injections initially, while others transition to longer intervals based on retinal imaging and examination findings.

AMD rarely causes complete blindness because it primarily affects central vision rather than peripheral vision. However, untreated macular degeneration can result in significant central vision loss, making everyday activities much more difficult. Early diagnosis and ongoing treatment are essential.

Yes. Your ophthalmologist may recommend:

• Quitting smoking
• Eating a diet rich in leafy green vegetables and fish
• Managing blood pressure and cholesterol
• Wearing UV-protective sunglasses
• Exercising regularly
• Taking AREDS2 supplements if appropriate

Healthy lifestyle choices may help reduce the risk of disease progression.

The frequency of follow-up visits depends on the type and severity of your AMD. Patients with wet macular degeneration often require more frequent monitoring than those with dry AMD. Your ophthalmologist will create a follow-up schedule tailored to your condition.

Northwest Eye Physicians provides comprehensive diagnosis, monitoring, and treatment for age-related macular degeneration using advanced retinal imaging and personalized treatment plans. Their experienced ophthalmologists work closely with each patient to detect AMD early, preserve vision, and provide ongoing management for both dry and wet forms of the disease.